Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mesothelioma × dostarlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Endometrial Neoplasms 10 Uterine Cervical Neoplasms 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Pancreatic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Breast Neoplasms 3 Rectal Neoplasms 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer (LARC) 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Neuroendocrine 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1 Penile Neoplasms 1 Pathologic Complete Response 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 Mouth Neoplasms 1

Interventions

Pemetrexed 20 Cisplatin 17 Nivolumab 7 Gemcitabine 7 Carboplatin 7 durvalumab 5 Radiotherapy, Intensity-Modulated 4 Ipilimumab 4 Bevacizumab 4 tremelimumab 3 pembrolizumab 3 niraparib 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 Thoracoscopy 2 Surveys and Questionnaires 2 Sorafenib 2 Radiosurgery 2 Oxaliplatin 2 Magnesium Sulfate 2 Leucovorin 2 Imatinib Mesylate 2 Drug Therapy 2 Doxorubicin 2 Dexamethasone 2 Cyclophosphamide 2 sodium thiosulfate 1 pevonedistat 1 perflutren 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04940637 2023-05-12

UNITO-001

University of Turin, Italy

Phase 2 Unknown

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡